Nerve growth factor, pain, itch and inflammation: lessons from congenital insensitivity to pain with anhidrosis

References

• Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur. J. Pain10(4), 287–333 (2006).
   PubMed Web of Science ®Google Scholar
• Lacroix-Fralish ML, Mogil JS. Progress in genetic studies of pain and analgesia. Annu. Rev. Pharmacol. Toxicol.49, 97–121 (2009).
   PubMed Web of Science ®Google Scholar
• Mogil JS. Animal models of pain: progress and challenges. Nat. Rev. Neurosci.10(4), 283–294 (2009).
   PubMed Web of Science ®Google Scholar
• Craig AD. How do you feel? Interoception: the sense of the physiological condition of the body. Nat. Rev. Neurosci.3(8), 655–666 (2002).
   PubMed Web of Science ®Google Scholar
• Craig AD. A rat is not a monkey is not a human: comment on Mogil (Nature Rev. Neurosci.10, 283–294 [2009]). Nat. Rev. Neurosci.10(6), 466 (2009).
   PubMedGoogle Scholar
• Craig AD. How do you feel – now? The anterior insula and human awareness. Nat. Rev. Neurosci.10(1), 59–70 (2009).
   PubMed Web of Science ®Google Scholar
• Ikoma A, Steinhoff M, Stander S, Yosipovitch G, Schmelz M. The neurobiology of itch. Nat. Rev. Neurosci.7(7), 535–547 (2006).
   PubMed Web of Science ®Google Scholar
• Steinhoff M, Bienenstock J, Schmelz M, Maurer M, Wei E, Biro T. Neurophysiological, neuroimmunological, and neuroendocrine basis of pruritus. J. Invest. Dermatol.126(8), 1705–1718 (2006).
   PubMed Web of Science ®Google Scholar
• Miller G. Biomedicine. Grasping for clues to the biology of itch. Science318(5848), 188–189 (2007).
   PubMedGoogle Scholar
• Roosterman D, Goerge T, Schneider SW, Bunnett NW, Steinhoff M. Neuronal control of skin function: the skin as a neuroimmunoendocrine organ. Physiol. Rev.86(4), 1309–1379 (2006).
   PubMed Web of Science ®Google Scholar
• Schmelz M, Handwerker HO. Itch. In: Wall and Melzack’s Textbook of Pain.McMahon SB, Kolzenburg M (Eds.), Elsevier, Philadelphia, PA, USA, 219–227 (2006).
   Google Scholar
• Stander S, Schmelz M. Chronic itch and pain – similarities and differences. Eur. J. Pain10(5), 473–478 (2006).
   PubMed Web of Science ®Google Scholar
• Stander S, Weisshaar E, Luger TA. Neurophysiological and neurochemical basis of modern pruritus treatment. Exp. Dermatol.17(3), 161–169 (2008).
   PubMed Web of Science ®Google Scholar
• Paus R, Schmelz M, Biro T, Steinhoff M. Frontiers in pruritus research: scratching the brain for more effective itch therapy. J. Clin. Invest.116(5), 1174–1186 (2006).
   PubMed Web of Science ®Google Scholar
• Biro T, Ko MC, Bromm B et al. How best to fight that nasty itch – from new insights into the neuroimmunological, neuroendocrine, and neurophysiological bases of pruritus to novel therapeutic approaches. Exp. Dermatol.14(3), 225–240 (2005).
   PubMed Web of Science ®Google Scholar
• Aloe L. Rita Levi-Montalcini: the discovery of nerve growth factor and modern neurobiology. Trends Cell. Biol.14(7), 395–399 (2004).
   PubMed Web of Science ®Google Scholar
• Levi-Montalcini R. The nerve growth factor 35 years later. Science237(4819), 1154–1162 (1987).
   PubMed Web of Science ®Google Scholar
• Pezet S, McMahon SB. Neurotrophins: mediators and modulators of pain. Annu. Rev. Neurosci.29, 507–538 (2006).
   PubMed Web of Science ®Google Scholar
• Reichardt LF. Neurotrophin-regulated signalling pathways. Philos. Trans. R. Soc. Lond. B. Biol. Sci.361(1473), 1545–1564 (2006).
   PubMed Web of Science ®Google Scholar
• Roux PP, Barker PA. Neurotrophin signaling through the p75 neurotrophin receptor. Prog. Neurobiol.67(3), 203–233 (2002).
   PubMed Web of Science ®Google Scholar
• Barker PA. High affinity not in the vicinity? Neuron53(1), 1–4 (2007).
   PubMed Web of Science ®Google Scholar
• Chao MV, Rajagopal R, Lee FS. Neurotrophin signalling in health and disease. Clin. Sci. (Lond.)110(2), 167–173 (2006).
   PubMed Web of Science ®Google Scholar
• Huang EJ, Reichardt LF. Neurotrophins: roles in neuronal development and function. Annu. Rev. Neurosci.24, 677–736 (2001).
   PubMed Web of Science ®Google Scholar
• Huang EJ, Reichardt LF. Trk receptors: roles in neuronal signal transduction. Annu. Rev. Biochem.72, 609–642 (2003).
   PubMed Web of Science ®Google Scholar
• Miller FD, Kaplan DR. On Trk for retrograde signaling. Neuron32(5), 767–770 (2001).
   PubMed Web of Science ®Google Scholar
• Wehrman T, He X, Raab B, Dukipatti A, Blau H, Garcia KC. Structural and mechanistic insights into nerve growth factor interactions with the TrkA and p75 receptors. Neuron53(1), 25–38 (2007).
   PubMedGoogle Scholar
• Foulkes T, Wood JN. Pain genes. PLoS Genet.4(7), e1000086 (2008).
   PubMedGoogle Scholar
• Oertel B, Lotsch J. Genetic mutations that prevent pain: implications for future pain medication. Pharmacogenomics9(2), 179–194 (2008).
   PubMed Web of Science ®Google Scholar
• Auer-Grumbach M, Mauko B, Auer-Grumbach P, Pieber TR. Molecular genetics of hereditary sensory neuropathies. Neuromolecular Med.8(1–2), 147–158 (2006).
   PubMedGoogle Scholar
• Axelrod FB, Chelimsky GG, Weese-Mayer DE. Pediatric autonomic disorders. Pediatrics118(1), 309–321 (2006).
   PubMedGoogle Scholar
• Freeman R. Autonomic peripheral neuropathy. Lancet365(9466), 1259–1270 (2005).
   PubMed Web of Science ®Google Scholar
• Indo Y. Molecular basis of congenital insensitivity to pain with anhidrosis (CIPA): mutations and polymorphisms in TRKA (NTRK1) gene encoding the receptor tyrosine kinase for nerve growth factor. Hum. Mutat.18(6), 462–471 (2001).
   PubMed Web of Science ®Google Scholar
• Indo Y. Genetics of congenital insensitivity to pain with anhidrosis (CIPA) or hereditary sensory and autonomic neuropathy type IV. Clinical, biological and molecular aspects of mutations in TRKA (NTRK1) gene encoding the receptor tyrosine kinase for nerve growth factor. Clin. Auton. Res.12(Suppl. 1), I20–I32 (2002).
   PubMedGoogle Scholar
• Indo Y. Congenital insensitivity to pain. In: The Genetics of Pain. Mogil JS (Ed.), IASP Press, Seattle, WA, USA, 171–191 (2004).
   Google Scholar
• Indo Y. Nerve growth factor, interoception, and sympathetic neuron: lesson from congenital insensitivity to pain with anhidrosis. Auton. Neurosci.147(1–2), 3–8 (2009).
   PubMedGoogle Scholar
• Rotthier A, Baets J, De Vriendt E et al. Genes for hereditary sensory and autonomic neuropathies: a genotype-phenotype correlation. Brain132(Pt 10), 2699–2711 (2009).
   PubMedGoogle Scholar
• Indo Y, Mardy S, Miura Y et al. Congenital insensitivity to pain with anhidrosis (CIPA): novel mutations of the TRKA(NTRK1) gene, a putative uniparental disomy, and a linkage of the mutant TRKA and PKLR genes in a family with CIPA and pyruvate kinase deficiency. Hum. Mutat.18(4), 308–318 (2001).
   PubMedGoogle Scholar
• Indo Y, Tsuruta M, Hayashida Y et al. Mutations in the TRKA/NGF receptor gene in patients with congenital insensitivity to pain with anhidrosis. Nat. Genet.13(4), 485–488 (1996).
   PubMed Web of Science ®Google Scholar
• Mardy S, Miura Y, Endo F, Matsuda I, Indo Y. Congenital insensitivity to pain with anhidrosis (CIPA): effect of TRKA (NTRK1) missense mutations on autophosphorylation of the receptor tyrosine kinase for nerve growth factor. Hum. Mol. Genet.10(3), 179–188 (2001).
   PubMedGoogle Scholar
• Mardy S, Miura Y, Endo F et al. Congenital insensitivity to pain with anhidrosis: novel mutations in the TRKA (NTRK1) gene encoding a high-affinity receptor for nerve growth factor. Am. J. Hum. Genet.64(6), 1570–1579 (1999).
   PubMedGoogle Scholar
• Miura Y, Mardy S, Awaya Y et al. Mutation and polymorphism analysis of the TRKA(NTRK1) gene encoding a high-affinity receptor for nerve growth factor in congenital insensitivity to pain with anhidrosis (CIPA) families. Hum. Genet.106(1), 116–124 (2000).
   PubMed Web of Science ®Google Scholar
• Kumazawa T. The polymodal receptor: bio-warning and defense system. In: Prog. Brain Res. (113). The Polymodal Receptor – a Gateway to Pathological Pain. Kumazawa T, Kruger L, Mizumura K (Eds.). Elsevier, Amsterdam, the Netherlands, 3–18 (1996).
   Google Scholar
• Schmelz M, Schmidt R, Bickel A, Handwerker HO, Torebjork HE. Specific C-receptors for itch in human skin. J. Neurosci.17(20), 8003–8008 (1997).
   PubMed Web of Science ®Google Scholar
• Ikoma A, Handwerker H, Miyachi Y, Schmelz M. Electrically evoked itch in humans. Pain113(1–2), 148–154 (2005).
   PubMedGoogle Scholar
• Johanek LM, Meyer RA, Hartke T et al. Psychophysical and physiological evidence for parallel afferent pathways mediating the sensation of itch. J. Neurosci.27(28), 7490–7497 (2007).
   PubMed Web of Science ®Google Scholar
• Mense S. Algesic agents exciting muscle nociceptors. Exp. Brain Res.196(1), 89–100 (2009).
   PubMed Web of Science ®Google Scholar
• Meyer RA, Ringkamp M, Campbell JN, Raja SN. Peripheral mechanisms of cutaneous nociception. In: Wall and Melzack’s Textbook of Pain. McMahon SB, Kolzenburg M (Eds). Elsevier, PA, USA, 3–34 (2006).
   Google Scholar
• Izumi H. Nervous control of blood flow in the orofacial region. Pharmacol. Ther.81(2), 141–161 (1999).
   PubMedGoogle Scholar
• Brogden KA, Guthmiller JM, Salzet M, Zasloff M. The nervous system and innate immunity: the neuropeptide connection. Nat. Immunol.6(6), 558–564 (2005).
   PubMed Web of Science ®Google Scholar
• Craig AD. Interoception and Emotion. In: Handbook of Emotions. Lewis M, Haviland-Jones JM, Barrett LF (Eds). The Guilford Press, New York, NY, USA, 272–288 (2008).
   Google Scholar
• Damasio AR. Descartes’ Error: Emotion, Reason, and the Human Brain.Putnam, New York, NY, USA (1994).
   Google Scholar
• Damasio AR. Looking for Spinoza.Harcourt, Orlando, FL, USA (2003).
   Google Scholar
• Wiens S. Interoception in emotional experience. Curr. Opin. Neurol.18(4), 442–447 (2005).
   PubMed Web of Science ®Google Scholar
• Julius D, Basbaum AI. Molecular mechanisms of nociception. Nature413(6852), 203–210 (2001).
   PubMed Web of Science ®Google Scholar
• Holzer P. Neurogenic vasodilatation and plasma leakage in the skin. Gen. Pharmacol.30(1), 5–11 (1998).
   PubMedGoogle Scholar
• Sauerstein K, Klede M, Hilliges M, Schmelz M. Electrically evoked neuropeptide release and neurogenic inflammation differ between rat and human skin. J. Physiol.529(Pt 3), 803–810 (2000).
   PubMed Web of Science ®Google Scholar
• Schmelz M, Zeck S, Raithel M, Rukwied R. Mast cell tryptase in dermal neurogenic inflammation. Clin. Exp. Allergy29(5), 695–702 (1999).
   PubMedGoogle Scholar
• Weidner C, Klede M, Rukwied R et al. Acute effects of substance P and calcitonin gene-related peptide in human skin – a microdialysis study. J. Invest. Dermatol.115(6), 1015–1020 (2000).
   PubMedGoogle Scholar
• Smeyne RJ, Klein R, Schnapp A et al. Severe sensory and sympathetic neuropathies in mice carrying a disrupted Trk/NGF receptor gene. Nature368(6468), 246–249 (1994).
   PubMed Web of Science ®Google Scholar
• Fagan AM, Garber M, Barbacid M, Silos-Santiago I, Holtzman DM. A role for TrkA during maturation of striatal and basal forebrain cholinergic neurons in vivo.J. Neurosci.17(20), 7644–7654 (1997).
   PubMedGoogle Scholar
• Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES. The sympathetic nerve – an integrative interface between two supersystems: the brain and the immune system. Pharmacol. Rev.52(4), 595–638 (2000).
   PubMed Web of Science ®Google Scholar
• Paus R, Theoharides TC, Arck PC. Neuroimmunoendocrine circuitry of the ‘brain–skin connection’. Trends Immunol.27(1), 32–39 (2006).
   PubMed Web of Science ®Google Scholar
• Chrousos GP. The hypothalamic–pituitary–adrenal axis and immune-mediated inflammation. N. Engl. J. Med.332(20), 1351–1362 (1995).
   PubMed Web of Science ®Google Scholar
• Chrousos GP. Stressors, stress, and neuroendocrine integration of the adaptive response. The 1997 Hans Selye Memorial Lecture. Ann. NY Acad. Sci.851, 311–335 (1998).
   PubMed Web of Science ®Google Scholar
• Chrousos GP. Stress, chronic inflammation, and emotional and physical well-being: concurrent effects and chronic sequelae. J. Allergy Clin. Immunol.106(5 Suppl), S275–S291 (2000).
   PubMedGoogle Scholar
• Elenkov IJ. Neurohormonal–cytokine interactions: implications for inflammation, common human diseases and well-being. Neurochem. Int.52(1–2), 40–51 (2008).
   PubMed Web of Science ®Google Scholar
• Sternberg EM. Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens. Nat. Rev. Immunol.6(4), 318–328 (2006).
   PubMed Web of Science ®Google Scholar
• Tracey KJ. The inflammatory reflex. Nature420(6917), 853–859 (2002).
   PubMed Web of Science ®Google Scholar
• Zoumakis E, Kalantaridou SN, Chrousos GP. The “brain–skin connection”: nerve growth factor-dependent pathways for stress-induced skin disorders. J. Mol. Med.85(12), 1347–1349 (2007).
   PubMedGoogle Scholar
• Mizumura K, Sugiura T, Katanosaka K, Banik RK, Kozaki Y. Excitation and sensitization of nociceptors by bradykinin: what do we know? Exp. Brain Res.196(1), 53–65 (2009).
   PubMed Web of Science ®Google Scholar
• Dallos A, Kiss M, Polyanka H, Dobozy A, Kemeny L, Husz S. Effects of the neuropeptides substance P, calcitonin gene-related peptide, vasoactive intestinal polypeptide and galanin on the production of nerve growth factor and inflammatory cytokines in cultured human keratinocytes. Neuropeptides40(4), 251–263 (2006).
   PubMed Web of Science ®Google Scholar
• Galli SJ, Tsai M, Piliponsky AM. The development of allergic inflammation. Nature454(7203), 445–454 (2008).
   PubMed Web of Science ®Google Scholar
• Nockher WA, Renz H. Neurotrophins in allergic diseases: from neuronal growth factors to intercellular signaling molecules. J. Allergy Clin. Immunol.117(3), 583–589 (2006).
   PubMed Web of Science ®Google Scholar
• Costigan M, Scholz J, Woolf CJ. Neuropathic pain: a maladaptive response of the nervous system to damage. Annu. Rev. Neurosci.32, 1–32 (2009).
   PubMed Web of Science ®Google Scholar
• Bielefeldt K, Lamb K, Gebhart GF. Convergence of sensory pathways in the development of somatic and visceral hypersensitivity. Am. J. Physiol. Gastrointest. Liver Physiol.291(4), G658–G665 (2006).
   Google Scholar
• Winston JH, Xu GY, Sarna SK. Adrenergic stimulation mediates visceral hypersensitivity to colorectal distension following heterotypic chronic stress. Gastroenterology138(1), 294–304 e3 (2010).
   PubMedGoogle Scholar
• Marchand F, Perretti M, McMahon SB. Role of the immune system in chronic pain. Nat. Rev. Neurosci.6(7), 521–532 (2005).
   PubMed Web of Science ®Google Scholar
• Devor M. Ectopic discharge in Abeta afferents as a source of neuropathic pain. Exp. Brain Res.196(1), 115–128 (2009).
   PubMed Web of Science ®Google Scholar
• Scadding JW, Koltzenburg M. Painful peripheral neuropathies. In: Wall and Melzack’s Textbook of Pain. McMahon SB, Kolzenburg M (Eds). Elsevier, PA, USA, 973–999 (2006).
   Google Scholar
• Ogata M, Misago N, Suzuki Y et al. A case of herpes zoster in a child with congenital insensitivity to pain with anhidrosis. Br. J. Dermatol.156(5), 1084–1086 (2007).
   PubMedGoogle Scholar
• Seal RP, Wang X, Guan Y et al. Injury-induced mechanical hypersensitivity requires C-low threshold mechanoreceptors. Nature462(7273), 651–655 (2009).
   PubMedGoogle Scholar
• Schmelz M. How pain becomes itch. Pain144(1–2), 14–15 (2009).
   PubMedGoogle Scholar
• Andrew D, Craig AD. Spinothalamic lamina I neurons selectively sensitive to histamine: a central neural pathway for itch. Nat. Neurosci.4(1), 72–77 (2001).
   PubMed Web of Science ®Google Scholar
• Schmelz M. A neural pathway for itch. Nat. Neurosci.4(1), 9–10 (2001).
   PubMed Web of Science ®Google Scholar
• Davidson S, Zhang X, Yoon CH, Khasabov SG, Simone DA, Giesler GJ Jr. The itch-producing agents histamine and cowhage activate separate populations of primate spinothalamic tract neurons. J. Neurosci.27(37), 10007–10014 (2007).
   PubMed Web of Science ®Google Scholar
• Simone DA, Zhang X, Li J et al. Comparison of responses of primate spinothalamic tract neurons to pruritic and algogenic stimuli. J. Neurophysiol.91(1), 213–222 (2004).
   PubMedGoogle Scholar
• Imamachi N, Park GH, Lee H et al. TRPV1-expressing primary afferents generate behavioral responses to pruritogens via multiple mechanisms. Proc. Natl Acad. Sci. USA106(27), 11330–11335 (2009).
   PubMed Web of Science ®Google Scholar
• Sikand P, Shimada SG, Green BG, LaMotte RH. Similar itch and nociceptive sensations evoked by punctate cutaneous application of capsaicin, histamine and cowhage. Pain144(1–2), 66–75 (2009).
   PubMed Web of Science ®Google Scholar
• Sun YG, Chen ZF. A gastrin-releasing peptide receptor mediates the itch sensation in the spinal cord. Nature448(7154), 700–703 (2007).
   PubMed Web of Science ®Google Scholar
• Sun YG, Zhao ZQ, Meng XL, Yin J, Liu XY, Chen ZF. Cellular basis of itch sensation. Science325(5947), 1531–1534 (2009).
   PubMed Web of Science ®Google Scholar
• Kerr BJ, Bradbury EJ, Bennett DL et al. Brain-derived neurotrophic factor modulates nociceptive sensory inputs and NMDA-evoked responses in the rat spinal cord. J. Neurosci.19(12), 5138–5148 (1999).
   PubMed Web of Science ®Google Scholar
• Lewin GR, Rueff A, Mendell LM. Peripheral and central mechanisms of NGF-induced hyperalgesia. Eur J. Neurosci.6(12), 1903–1912 (1994).
   PubMed Web of Science ®Google Scholar
• Thompson SW, Bennett DL, Kerr BJ, Bradbury EJ, McMahon SB. Brain-derived neurotrophic factor is an endogenous modulator of nociceptive responses in the spinal cord. Proc. Natl Acad. Sci. USA96(14), 7714–7718 (1999).
   PubMedGoogle Scholar
• Joachim RA, Kuhlmei A, Dinh QT et al. Neuronal plasticity of the ‘brain-skin connection’: stress-triggered up-regulation of neuropeptides in dorsal root ganglia and skin via nerve growth factor-dependent pathways. J. Mol. Med.85(12), 1369–1378 (2007).
   PubMed Web of Science ®Google Scholar
• Hendrix S, Peters EM. Neuronal plasticity and neuroregeneration in the skin – the role of inflammation. J. Neuroimmunol.184(1–2), 113–126 (2007).
   PubMedGoogle Scholar
• Allen SJ, Dawbarn D. Clinical relevance of the neurotrophins and their receptors. Clin. Sci. (Lond.)110(2), 175–191 (2006).
   PubMed Web of Science ®Google Scholar
• Guerios SD, Wang ZY, Boldon K, Bushman W, Bjorling DE. Blockade of NGF and trk receptors inhibits increased peripheral mechanical sensitivity accompanying cystitis in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol.295(1), R111–R122 (2008).
   Google Scholar
• Hefti FF, Rosenthal A, Walicke PA et al. Novel class of pain drugs based on antagonism of NGF. Trends Pharmacol. Sci.27(2), 85–91 (2006).
   PubMedGoogle Scholar
• McMahon SB, Bennett DLH, Bevan S. Inflammatory mediators and modulators of pain. In: Wall and Melzack’s Textbook of Pain. McMahon SB, Kolzenburg M (Eds). Elsevier, PA, USA, 49–72 (2006).
   Google Scholar
• Obata K, Noguchi K. BDNF in sensory neurons and chronic pain. Neurosci. Res.55(1), 1–10 (2006).
   PubMed Web of Science ®Google Scholar
• Tominaga M, Tominaga T. Structure and function of TRPV1. Pflugers Arch.451(1), 143–150 (2005).
   PubMed Web of Science ®Google Scholar
• Diss JK, Calissano M, Gascoyne D, Djamgoz MB, Latchman DS. Identification and characterization of the promoter region of the Nav1.7 voltage-gated sodium channel gene (SCN9A).Mol. Cell Neurosci.37(3), 537–547 (2008).
   PubMedGoogle Scholar
• Fjell J, Cummins TR, Dib-Hajj SD, Fried K, Black JA, Waxman SG. Differential role of GDNF and NGF in the maintenance of two TTX-resistant sodium channels in adult DRG neurons. Brain Res. Mol. Brain Res.67(2), 267–282 (1999).
   PubMedGoogle Scholar
• Fjell J, Cummins TR, Fried K, Black JA, Waxman SG. In vivo NGF deprivation reduces SNS expression and TTX-R sodium currents in IB4-negative DRG neurons. J. Neurophysiol.81(2), 803–810 (1999).
   PubMed Web of Science ®Google Scholar
• Gould HJ 3rd, Gould TN, England JD, Paul D, Liu ZP, Levinson SR. A possible role for nerve growth factor in the augmentation of sodium channels in models of chronic pain. Brain Res.854(1–2), 19–29 (2000).
   PubMed Web of Science ®Google Scholar
• Jia Z, Bei J, Rodat-Despoix L et al. NGF inhibits M/KCNQ currents and selectively alters neuronal excitability in subsets of sympathetic neurons depending on their M/KCNQ current background. J. Gen. Physiol.131(6), 575–587 (2008).
   PubMedGoogle Scholar
• Willis DE, van Niekerk EA, Sasaki Y et al. Extracellular stimuli specifically regulate localized levels of individual neuronal mRNAs. J. Cell Biol.178(6), 965–980 (2007).
   PubMed Web of Science ®Google Scholar
• Janig W, Levine JD. Autonomic-endocrine-immune interactions in acute and chronic pain. In: Wall and Melzack’s Textbook of Pain. McMahon SB, Kolzenburg M (Eds). Elsevier, PA, USA, 205–218 (2006).
   Google Scholar
• Luther JA, Birren SJ. p75 and TrkA signaling regulates sympathetic neuronal firing patterns via differential modulation of voltage-gated currents. J. Neurosci.29(17), 5411–5424 (2009).
   PubMedGoogle Scholar
• Bjerre B, Bjorklund A, Mobley W, Rosengren E. Short- and long-term effects of nerve growth factor on the sympathetic nervous system in the adult mouse. Brain Res.94(2), 263–277 (1975).
   PubMedGoogle Scholar
• Glebova NO, Ginty DD. Heterogeneous requirement of NGF for sympathetic target innervation in vivo.J. Neurosci.24(3), 743–751 (2004).
   PubMedGoogle Scholar
• Ford CP, Wong KV, Lu VB, Posse de Chaves E, Smith PA. Differential neurotrophic regulation of sodium and calcium channels in an adult sympathetic neuron. J. Neurophysiol.99(3), 1319–1332 (2008).
   PubMedGoogle Scholar
• Lei S, Dryden WF, Smith PA. Nerve growth factor regulates sodium but not potassium channel currents in sympathetic B neurons of adult bullfrogs. J. Neurophysiol.86(2), 641–650 (2001).
   PubMedGoogle Scholar
• Lei S, Dryden WF, Smith PA. Regulation of N- and L-type Ca2+ channels in adult frog sympathetic ganglion B cells by nerve growth factor in vitro and in vivo.J. Neurophysiol.78(6), 3359–3370 (1997).
   PubMedGoogle Scholar
• Luther JA, Birren SJ. Nerve growth factor decreases potassium currents and alters repetitive firing in rat sympathetic neurons. J. Neurophysiol.96(2), 946–958 (2006).
   PubMedGoogle Scholar
• Nockher WA, Renz H. Neurotrophins and asthma: novel insight into neuroimmune interaction. J. Allergy Clin. Immunol.117(1), 67–71 (2006).
   PubMed Web of Science ®Google Scholar
• Takei Y, Laskey R. Interpreting crosstalk between TNF-α and NGF: potential implications for disease. Trends Mol. Med.14(9), 381–388 (2008).
   PubMed Web of Science ®Google Scholar
• Freund-Michel V, Frossard N. The nerve growth factor and its receptors in airway inflammatory diseases. Pharmacol. Ther.117(1), 52–76 (2008).
   PubMed Web of Science ®Google Scholar
• Nassenstein C, Schulte-Herbruggen O, Renz H, Braun A. Nerve growth factor: the central hub in the development of allergic asthma? Eur. J. Pharmacol.533(1–3), 195–206 (2006).
   PubMed Web of Science ®Google Scholar
• Seidel MF, Herguijuela M, Forkert R, Otten U. Nerve growth factor in rheumatic diseases. Semin. Arthritis Rheum. DOI: S0049–0172(09)00035–3 [pii]10.1016/j.semarthrit.2009.03.002 (2009) (Epub ahead of print).
   Google Scholar
• Boguniewicz M, Schmid-Grendelmeier P, Leung DY. Atopic dermatitis. J. Allergy Clin. Immunol.118(1), 40–43 (2006).
   PubMedGoogle Scholar
• Botchkarev VA, Yaar M, Peters EM et al. Neurotrophins in skin biology and pathology. J. Invest. Dermatol.126(8), 1719–1727 (2006).
   PubMedGoogle Scholar
• Takaoka K, Shirai Y, Saito N. Inflammatory cytokine tumor necrosis factor-α enhances nerve growth factor production in human keratinocytes, HaCaT cells. J. Pharmacol. Sci.111(4), 381–391 (2009).
   PubMed Web of Science ®Google Scholar
• Dou YC, Hagstromer L, Emtestam L, Johansson O. Increased nerve growth factor and its receptors in atopic dermatitis: an immunohistochemical study. Arch. Dermatol. Res.298(1), 31–37 (2006).
   PubMedGoogle Scholar
• Shaker OG, El-Komy M, Tawfic SO, Zeidan N, Tomairek RH. Possible role of nerve growth factor and interleukin-18 in pathogenesis of eczematous lesions of atopic dermatitis. J. Dermatol. Sci.53(2), 153–154 (2009).
   PubMedGoogle Scholar
• Tominaga M, Tengara S, Kamo A, Ogawa H, Takamori K. Psoralen-ultraviolet A therapy alters epidermal Sema3A and NGF levels and modulates epidermal innervation in atopic dermatitis. J. Dermatol. Sci.55(1), 40–46 (2009).
   PubMed Web of Science ®Google Scholar
• Yamaguchi J, Aihara M, Kobayashi Y, Kambara T, Ikezawa Z. Quantitative analysis of nerve growth factor (NGF) in the atopic dermatitis and psoriasis horny layer and effect of treatment on NGF in atopic dermatitis. J. Dermatol. Sci.53(1), 48–54 (2009).
   PubMed Web of Science ®Google Scholar
• Horiuchi Y, Bae S, Katayama I. Nerve growth factor (NGF) and epidermal nerve fibers in atopic dermatitis model NC/Nga mice. J. Dermatol. Sci.39(1), 56–58 (2005).
   PubMedGoogle Scholar
• Tanaka A, Matsuda H. Expression of nerve growth factor in itchy skins of atopic NC/NgaTnd mice. J. Vet. Med. Sci.67(9), 915–919 (2005).
   PubMed Web of Science ®Google Scholar
• Tokime K, Katoh-Semba R, Yamanaka K, Mizoguchi A, Mizutani H. Enhanced production and secretion of glial cell line-derived neurotrophic factor and nerve growth factor from the skin in atopic dermatitis mouse model. Arch. Dermatol. Res.300(7), 343–352 (2008).
   PubMed Web of Science ®Google Scholar
• Tominaga M, Ozawa S, Ogawa H, Takamori K. A hypothetical mechanism of intraepidermal neurite formation in NC/Nga mice with atopic dermatitis. J. Dermatol. Sci.46(3), 199–210 (2007).
   PubMedGoogle Scholar
• Tominaga M, Ozawa S, Tengara S, Ogawa H, Takamori K. Intraepidermal nerve fibers increase in dry skin of acetone-treated mice. J. Dermatol. Sci.48(2), 103–111 (2007).
   PubMed Web of Science ®Google Scholar
• Yamaoka J, Di ZH, Sun W, Kawana S. Erratum to “changes in cutaneous sensory nerve fibers induced by skin-scratching in mice”. J. Dermatol. Sci.47(2), 172–182 (2007).
   PubMedGoogle Scholar
• Yoshioka T, Hikita I, Asakawa M et al. Spontaneous scratching behaviour in DS-Nh mice as a possible model for pruritus in atopic dermatitis. Immunology118(3), 293–301 (2006).
   PubMedGoogle Scholar
• Sugiura H, Omoto M, Hirota Y, Danno K, Uehara M. Density and fine structure of peripheral nerves in various skin lesions of atopic dermatitis. Arch. Dermatol. Res.289(3), 125–131 (1997).
   PubMed Web of Science ®Google Scholar
• Urashima R, Mihara M. Cutaneous nerves in atopic dermatitis. A histological, immunohistochemical and electron microscopic study. Virchows Arch.432(4), 363–370 (1998).
   PubMed Web of Science ®Google Scholar
• Bresciani M, Laliberte F, Laliberte MF, Gramiccioni C, Bonini S. Nerve growth factor localization in the nasal mucosa of patients with persistent allergic rhinitis. Allergy64(1), 112–117 (2009).
   PubMed Web of Science ®Google Scholar
• Coffey CS, Mulligan RM, Schlosser RJ. Mucosal expression of nerve growth factor and brain-derived neurotrophic factor in chronic rhinosinusitis. Am. J. Rhinol. Allergy23(6), 571–574 (2009).
   PubMedGoogle Scholar
• O’Hanlon S, Facer P, Simpson KD, Sandhu G, Saleh HA, Anand P. Neuronal markers in allergic rhinitis: expression and correlation with sensory testing. Laryngoscope117(9), 1519–1527 (2007).
   PubMed Web of Science ®Google Scholar
• Raap U, Braunstahl GJ. The role of neurotrophins in the pathophysiology of allergic rhinitis. Curr. Opin. Allergy Clin. Immunol.10(1), 8–13 (2010).
   PubMed Web of Science ®Google Scholar
• Raap U, Fokkens W, Bruder M, Hoogsteden H, Kapp A, Braunstahl GJ. Modulation of neurotrophin and neurotrophin receptor expression in nasal mucosa after nasal allergen provocation in allergic rhinitis. Allergy63(4), 468–475 (2008).
   PubMedGoogle Scholar
• Sanico AM, Stanisz AM, Gleeson TD et al. Nerve growth factor expression and release in allergic inflammatory disease of the upper airways. Am. J. Respir. Crit. Care Med.161(5), 1631–1635 (2000).
   PubMed Web of Science ®Google Scholar
• Wu X, Myers AC, Goldstone AC, Togias A, Sanico AM. Localization of nerve growth factor and its receptors in the human nasal mucosa. J. Allergy Clin. Immunol.118(2), 428–433 (2006).
   PubMed Web of Science ®Google Scholar
• de Vries A, Engels F, Henricks PA et al. Airway hyper-responsiveness in allergic asthma in guinea-pigs is mediated by nerve growth factor via the induction of substance P: a potential role for trkA. Clin. Exp. Allergy36(9), 1192–1200 (2006).
   PubMed Web of Science ®Google Scholar
• El-Hashim AZ, Jaffal SM. Nerve growth factor enhances cough and airway obstruction via TrkA receptor- and TRPV1-dependent mechanisms. Thorax64(9), 791–797 (2009).
   PubMedGoogle Scholar
• Nassenstein C, Dawbarn D, Pollock K et al. Pulmonary distribution, regulation, and functional role of Trk receptors in a murine model of asthma. J. Allergy Clin. Immunol.118(3), 597–605 (2006).
   PubMedGoogle Scholar
• Quarcoo D, Schulte-Herbruggen O, Lommatzsch M et al. Nerve growth factor induces increased airway inflammation via a neuropeptide-dependent mechanism in a transgenic animal model of allergic airway inflammation. Clin. Exp. Allergy34(7), 1146–1151 (2004).
   PubMed Web of Science ®Google Scholar
• Bachar O, Adner M, Uddman R, Cardell LO. Nerve growth factor enhances cholinergic innervation and contractile response to electric field stimulation in a murine in vitro model of chronic asthma. Clin. Exp. Allergy34(7), 1137–1145 (2004).
   PubMed Web of Science ®Google Scholar
• Hazari MS, Pan JH, Myers AC. Nerve growth factor acutely potentiates synaptic transmission in vitro and induces dendritic growth in vivo on adult neurons in airway parasympathetic ganglia. Am. J. Physiol. Lung Cell. Mol. Physiol.292(4), L992–L1001 (2007).
   PubMedGoogle Scholar
• Abram M, Wegmann M, Fokuhl V et al. Nerve growth factor and neurotrophin-3 mediate survival of pulmonary plasma cells during the allergic airway inflammation. J. Immunol.182(8), 4705–4712 (2009).
   PubMedGoogle Scholar
• Hahn C, Islamian AP, Renz H, Nockher WA. Airway epithelial cells produce neurotrophins and promote the survival of eosinophils during allergic airway inflammation. J. Allergy Clin. Immunol.117(4), 787–794 (2006).
   PubMed Web of Science ®Google Scholar
• Verbout NG, Jacoby DB, Gleich GJ, Fryer AD. Atropine-enhanced, antigen challenge-induced airway hyperreactivity in guinea pigs is mediated by eosinophils and nerve growth factor. Am. J. Physiol. Lung Cell. Mol. Physiol.297(2), L228–L237 (2009).
   Google Scholar
• Freund-Michel V, Frossard N. Overexpression of functional TrkA receptors after internalisation in human airway smooth muscle cells. Biochim. Biophys. Acta1783(10), 1964–1971 (2008).
   PubMedGoogle Scholar
• Frossard N, Naline E, Olgart Hoglund C, Georges O, Advenier C. Nerve growth factor is released by IL-1b and induces hyperresponsiveness of the human isolated bronchus. Eur. Respir. J.26(1), 15–20 (2005).
   PubMedGoogle Scholar
• Othumpangat S, Gibson LF, Samsell L, Piedimonte G. NGF is an essential survival factor for bronchial epithelial cells during respiratory syncytial virus infection. PLoS One4(7), e6444 (2009).
   PubMed Web of Science ®Google Scholar
• Tortorolo L, Langer A, Polidori G et al. Neurotrophin overexpression in lower airways of infants with respiratory syncytial virus infection. Am. J. Respir. Crit. Care Med.172(2), 233–237 (2005).
   PubMed Web of Science ®Google Scholar
• Piedimonte G. Contribution of neuroimmune mechanisms to airway inflammation and remodeling during and after respiratory syncytial virus infection. Pediatr. Infect. Dis. J.22(2 Suppl.), S66–S74; discussion S74–S65 (2003).
   PubMed Web of Science ®Google Scholar
• Schaible HG, Richter F, Ebersberger A et al. Joint pain. Exp. Brain Res.196(1), 153–162 (2009).
   PubMed Web of Science ®Google Scholar
• Scott DL. Osteoarthritis and rheumatoid arthritis. In: Wall and Melzack’s Textbook of Pain. McMahon SB, Kolzenburg M (Eds). Elsevier, PA, USA, 653–667 (2006).
   Google Scholar
• Niissalo S, Hukkanen M, Imai S, Tornwall J, Konttinen YT. Neuropeptides in experimental and degenerative arthritis. Ann. NY Acad. Sci.966, 384–399 (2002).
   PubMed Web of Science ®Google Scholar
• Schaible HG, Ebersberger A, Von Banchet GS. Mechanisms of pain in arthritis. Ann. NY Acad. Sci.966, 343–354 (2002).
   PubMed Web of Science ®Google Scholar
• Abe Y, Akeda K, An HS et al. Proinflammatory cytokines stimulate the expression of nerve growth factor by human intervertebral disc cells. Spine (Phila. Pa 1976)32(6), 635–642 (2007).
   PubMed Web of Science ®Google Scholar
• Barthel C, Yeremenko N, Jacobs R et al. Nerve growth factor and receptor expression in rheumatoid arthritis and spondyloarthritis. Arthritis Res. Ther.11(3), R82 (2009).
   PubMed Web of Science ®Google Scholar
• Purmessur D, Freemont AJ, Hoyland JA. Expression and regulation of neurotrophins in the nondegenerate and degenerate human intervertebral disc. Arthritis Res. Ther.10(4), R99 (2008).
   PubMed Web of Science ®Google Scholar
• Raychaudhuri SK, Raychaudhuri SP. NGF and its receptor system: a new dimension in the pathogenesis of psoriasis and psoriatic arthritis. Ann. NY Acad. Sci.1173, 470–477 (2009).
   PubMed Web of Science ®Google Scholar
• Raychaudhuri SP, Raychaudhuri SK. The regulatory role of nerve growth factor and its receptor system in fibroblast-like synovial cells. Scand. J. Rheumatol.38(3), 207–215 (2009).
   PubMed Web of Science ®Google Scholar
• Shelton DL, Zeller J, Ho WH, Pons J, Rosenthal A. Nerve growth factor mediates hyperalgesia and cachexia in auto-immune arthritis. Pain116(1–2), 8–16 (2005).
   PubMed Web of Science ®Google Scholar
• Surace MF, Prestamburgo D, Campagnolo M, Fagetti A, Murena L. Presence of NGF and its receptor TrkA in degenerative lumbar facet joint specimens. Eur. Spine J.18(Suppl. 1), 122–125 (2009).
   PubMed Web of Science ®Google Scholar
• Rukwied R, Mayer A, Kluschina O, Obreja O, Schley M, Schmelz M. NGF induces non-inflammatory localized and lasting mechanical and thermal hypersensitivity in human skin. Pain148(3), 407–413 (2010).
   PubMed Web of Science ®Google Scholar
• Wang T, Yu D, Lamb ML. Trk kinase inhibitors as new treatments for cancer and pain. Expert Opin. Ther. Pat.19(3), 305–319 (2009).
   PubMed Web of Science ®Google Scholar
• Watson JJ, Allen SJ, Dawbarn D. Targeting nerve growth factor in pain: what is the therapeutic potential? BioDrugs22(6), 349–359 (2008).
   PubMed Web of Science ®Google Scholar
• Cattaneo A. Tanezumab, a recombinant humanized mAb against nerve growth factor for the treatment of acute and chronic pain. Curr. Opin. Mol. Ther.12(1), 94–106 (2010).
   PubMedGoogle Scholar
• Eibl JK, Chapelsky SA, Ross GM. Multipotent neurotrophin antagonist targets brain-derived neurotrophic factor and nerve growth factor. J. Pharmacol. Exp. Ther.332(2), 446–454 (2010).
   PubMedGoogle Scholar
• McNamee KE, Burleigh A, Gompels LL et al. Treatmentof murine osteoarthritis with TrkAd5 reveals a pivotal role for nerve growth factor in non-inflammatory joint pain. Pain149(2), 386–392 (2010).
   PubMed Web of Science ®Google Scholar
• Dawbarn D, Fahey M, Watson J et al. NGF receptor TrkAd5: therapeutic agent and drug design target. Biochem. Soc. Trans.34(Pt 4), 587–590 (2006).
   PubMed Web of Science ®Google Scholar
• Halvorson KG, Kubota K, Sevcik MA et al. A blocking antibody to nerve growth factor attenuates skeletal pain induced by prostate tumor cells growing in bone. Cancer Res.65(20), 9426–9435 (2005).
   PubMed Web of Science ®Google Scholar
• Jimenez-Andrade JM, Martin CD, Koewler NJ et al. Nerve growth factor sequestering therapy attenuates non-malignant skeletal pain following fracture. Pain133(1–3), 183–196 (2007).
   PubMed Web of Science ®Google Scholar
• McMahon SB. NGF as a mediator of inflammatory pain. Philos. Trans. R. Soc. Lond. B. Biol. Sci.351(1338), 431–440 (1996).
   PubMed Web of Science ®Google Scholar
• Obata K, Katsura H, Mizushima T et al. TRPA1 induced in sensory neurons contributes to cold hyperalgesia after inflammation and nerve injury. J. Clin. Invest.115(9), 2393–2401 (2005).
   PubMed Web of Science ®Google Scholar
• Sabsovich I, Wei T, Guo TZ et al. Effect of anti-NGF antibodies in a rat tibia fracture model of complex regional pain syndrome type I. Pain138(1), 47–60 (2008).
   PubMedGoogle Scholar
• Sevcik MA, Ghilardi JR, Peters CM et al. Anti-NGF therapy profoundly reduces bone cancer pain and the accompanying increase in markers of peripheral and central sensitization. Pain115(1–2), 128–141 (2005).
   PubMed Web of Science ®Google Scholar
• Ugolini G, Marinelli S, Covaceuszach S, Cattaneo A, Pavone F. The function neutralizing anti-TrkA antibody MNAC13 reduces inflammatory and neuropathic pain. Proc. Natl Acad. Sci. USA104(8), 2985–2990 (2007).
   PubMed Web of Science ®Google Scholar
• Wild KD, Bian D, Zhu D et al. Antibodies to nerve growth factor reverse established tactile allodynia in rodent models of neuropathic pain without tolerance. J. Pharmacol. Exp. Ther.322(1), 282–287 (2007).
   PubMedGoogle Scholar
• Johansson O, Liang Y, Emtestam L. Increased nerve growth factor- and tyrosine kinase A-like immunoreactivities in prurigo nodularis skin – an exploration of the cause of neurohyperplasia. Arch. Dermatol. Res.293(12), 614–619 (2002).
   PubMed Web of Science ®Google Scholar
• Toyoda M, Nakamura M, Makino T, Hino T, Kagoura M, Morohashi M. Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis. Br. J. Dermatol.147(1), 71–79 (2002).
   PubMed Web of Science ®Google Scholar
• Stander S, Siepmann D, Herrgott I, Sunderkotter C, Luger TA. Targeting the neurokinin receptor 1 with aprepitant: a novel antipruritic strategy. PLoS One5(6), e10968 (2010).
   PubMed Web of Science ®Google Scholar
• Takano N, Sakurai T, Kurachi M. Effects of anti-nerve growth factor antibody on symptoms in the NC/Nga mouse, an atopic dermatitis model. J. Pharmacol. Sci.99(3), 277–286 (2005).
   PubMedGoogle Scholar
• Takano N, Sakurai T, Ohashi Y, Kurachi M. Effects of high-affinity nerve growth factor receptor inhibitors on symptoms in the NC/Nga mouse atopic dermatitis model. Br. J. Dermatol.156(2), 241–246 (2007).
   PubMed Web of Science ®Google Scholar
• Williams B, Granholm AC, Sambamurti K. Age-dependent loss of NGF signaling in the rat basal forebrain is due to disrupted MAPK activation. Neurosci. Lett.413(2), 110–114 (2007).
   PubMedGoogle Scholar
• Wu CW, Yeh HH. Nerve growth factor rapidly increases muscarinic tone in mouse medial septum/diagonal band of Broca. J. Neurosci.25(17), 4232–4242 (2005).
   PubMedGoogle Scholar
• Mufson EJ, Counts SE, Perez SE, Ginsberg SD. Cholinergic system during the progression of Alzheimer’s disease: therapeutic implications. Expert Rev. Neurother.8(11), 1703–1718 (2008).
   PubMedGoogle Scholar
• Ginsberg SD, Che S, Wuu J, Counts SE, Mufson EJ. Down regulation of Trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer’s disease. J. Neurochem.97(2), 475–487 (2006).
   PubMed Web of Science ®Google Scholar
• Tuszynski MH, Thal L, Pay M et al. A Phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat. Med.11(5), 551–555 (2005).
   PubMed Web of Science ®Google Scholar
• Adcock JJ. TRPV1 receptors in sensitisation of cough and pain reflexes. Pulm. Pharmacol. Ther.22(2), 65–70 (2009).
   PubMed Web of Science ®Google Scholar
• Gavva NR, Treanor JJ, Garami A et al. Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans. Pain136(1–2), 202–210 (2008).
   PubMed Web of Science ®Google Scholar
• Zhang X, Huang J, McNaughton PA. NGF rapidly increases membrane expression of TRPV1 heat-gated ion channels. Embo. J.24(24), 4211–4223 (2005).
   PubMed Web of Science ®Google Scholar
• Caterina MJ. Transient receptor potential ion channels as participants in thermosensation and thermoregulation. Am. J. Physiol. Regul. Integr. Comp. Physiol.292(1), R64–R76 (2007).
   PubMed Web of Science ®Google Scholar
• Talavera K, Nilius B, Voets T. Neuronal TRP channels: thermometers, pathfinders and life-savers. Trends Neurosci.31(6), 287–295 (2008).
   PubMed Web of Science ®Google Scholar
• Snider WD, McMahon SB. Tackling pain at the source: new ideas about nociceptors. Neuron20(4), 629–632 (1998).
   PubMed Web of Science ®Google Scholar
• Fang X, Djouhri L, McMullan S et al. Intense isolectin-B4 binding in rat dorsal root ganglion neurons distinguishes C-fiber nociceptors with broad action potentials and high Nav1.9 expression. J. Neurosci.26(27), 7281–7292 (2006).
   PubMed Web of Science ®Google Scholar
• Golden JP, Hoshi M, Nassar MA et al. RET signaling is required for survival and normal function of nonpeptidergic nociceptors. J. Neurosci.30(11), 3983–3994 (2010).
   PubMed Web of Science ®Google Scholar
• Luo W, Wickramasinghe SR, Savitt JM, Griffin JW, Dawson TM, Ginty DD. A hierarchical NGF signaling cascade controls Ret-dependent and Ret-independent events during development of nonpeptidergic DRG neurons. Neuron54(5), 739–754 (2007).
   PubMedGoogle Scholar
• Nicol GD, Vasko MR. Unraveling the story of NGF-mediated sensitization of nociceptive sensory neurons: ON or OFF the Trks? Mol. Interv.7(1), 26–41 (2007).
   PubMedGoogle Scholar